There is no doubt that migraines can alter your entire day into a whirlwind. But, taking the right medication and prompt treatment can spare you from this hassle.
As per studies migraine is the primary cause of more than 800,000 emergency cases across the United States annually. In addition, it is advised to take prescription medications that are approved from the FDA and recommended by medical professionals.
There are currently two oral medications that have been approved by the FDA to treat migraine that is episodic. They are Nurtec ODT and Qulipta. This article will give you Qulipta Review as well as detailed information on the product. Keep reading to find out more.
What is Qulipta?
Qulipta is one of the two oral medications used to treat chronic migraine of which is accepted from FDA (FDA) Food and Drug Administration in the United States.
In the year following Nurtec ODT, also called Rimegepant which was approved in the year 2020, Qulipta was the 2nd medication (atogepant) recognized as the oral anti-calcitonin drug and gene-related peptide used to treat migraine. Additionally, it’s an prescription medication designed for adults. However, it’s unclear if it is given to children.
In the coming sections we will provide more information details about the Qulipta Review and those who should be taking it as well as any adverse reactions to the drug.
Who Should Avoid Qulipta?
It is advised for patients to talk with a medical professional the situation of any of the following ailments:
- If you’re on dialysis or have kidney issues, you should consider it.
- Patients suffering from liver issues
- Breastfeeding mothers and pregnant womenwho are expecting to be pregnant.
It is not recommended to take together with other medicines such as:
- St. John’s Wort
- Ketoconazole / Itraconazole
What Are The Side Effects of Qulipta?
Like many other drugs, Qulipta may have some adverse effects, including:
Qulipta Reviews – What is The Patient Feedback?
Based on the research, Qulipta has an overall 4.2-star rating out of five. However, reviews aren’t all positive, and includes both positive and negative reviews.
One person who is 28 years old older and suffers from migraine says the medication can produce a dramatic effect on her. She says that none of the other treatments, including occipital nerve block, proved to be efficient. While she experienced dizziness in the beginning however, she was prescribed medication to treat it for 2.5 months. This proved efficient.
However another user claims that they started using Qulipta 60 mg daily. Though they didn’t experience any headache for the first week, and they felt dizzy, by the end of the fourth week, the migraine recurred. Based on Qulipta reviews the patient claims that they developed Covid prior to starting the medication. They suggest giving another try before making a switch.
However, some users have reported dizziness from the beginning, and have highlighted its effectiveness. It is therefore recommended for patients to talk to their physician and read reviews thoroughly before deciding to take the drug. It should be noted that all data and information is sourced from websites, and we have no authority over the subject.